首页|基于生物信息学的杆努尽烟治疗慢性支气管炎大鼠的分子机制

基于生物信息学的杆努尽烟治疗慢性支气管炎大鼠的分子机制

扫码查看
目的 基于生物信息学探讨杆努尽烟治疗慢性支气管炎(CB)大鼠的分子机制.方法 采用Lin-pinski规则筛选出杆努尽烟活性成分,UniProt预测潜在靶点,取Gene Cards与疾病靶点交集,String创建蛋白互作网络并创建"成分-靶点-通路"网络,基因本体数据库(GO)和京都基因与基因组百科全书(KEGG)富集分析交集靶点,AutoDock模拟活性成分-核心靶点的对接模式;30只大鼠随机均分为空白组(0.9%NaCl)、模型组(0.9%NaCl)、阳性药物(1g/kg桂龙咳喘宁)组及低剂量(2 g/kg)、高剂量(8 g/kg)杆努尽烟组,除空白组外其余组大鼠进行CB造模,造模结束后麻醉处死各组大鼠1只,取肺组织制作切片采用苏木精-伊红染色法(HE)判断造模成功与否;再按上述各组处理灌胃给药,1次/d、持续28 d,干预结束后麻醉处死余下各组大鼠,取肺组织和心脏取血,采用Western blot和反转录-聚合酶链反应(RT-PCR)检测肺组织中蛋白激酶B(AKT1)、过氧化物酶体增殖物激活受体γ(PPARγ)及激活核因子-κB p65(NF-κB p65)蛋白和mRNA表达,采用酶联免疫吸附测定(ELISA)法检测各组大鼠血清肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)及干扰素γ(INF-γ)水平.结果 杆努尽烟活性成分18个交集靶点92个,核心靶点AKT1、PPARγ等,GO-KEGG富集主要涉及免疫和炎症相关的磷脂酰肌醇3-酶d/蛋白激酶B(PI3K/Akt)、丝裂原活化蛋白激酶(MAPK)信号通路,分子对接示杆努尽烟活性成分与AKT1、PPARγ结合稳定;与空白组比较,模型组大鼠肺组织PPARγ蛋白及mRNA表达下降,NF-κB p65、AKT1蛋白及mRNA表达上升(P<0.05);与模型组比较,阳性药物组、低剂量杆努尽烟组、高剂量杆努尽烟组大鼠肺组织PPARγ蛋白及mRNA表达量均有不同程度的上升,NF-KB p65、AKT1蛋白及mRNA表达量均有一定程度的下降,高剂量杆努尽烟组大鼠肺组织表达差异最为明显(P<0.05);模型组和低剂量杆努尽烟组大鼠血清TNF-α、1L-1β及INF-γ水平较空白组升高(P<0.05),阳性药物组和高剂量杆努尽烟组大鼠血清TNF-α、IL-1β及INF-γ水平较模型组降低(P<0.05).结论 杆努尽烟可通过作用于AKT1、PPARγ、NF-κB p65发挥治疗CB大鼠的作用.
Mechanisms of Lysionotus pauciflorus Maxim.for the treatment of chronic bronchitis based on bioinformatics
Objective To explore the molecular mechanisms of Lysionotus pauciflorus Maxim.in treating chronic bronchitis(CB)in rats based on bioinformatics.Methods Active components of Lysionotus pauciflorus Maxim.were screened using the Lipinski rule.Potential targets were predicted with UniProt,intersected with disease targets from Gene Cards,and a protein interaction network was created with string to establish a"Component-Target-Pathway"network.Intersection targets were enriched and analyzed using the Gene Ontology Database and the Kyoto Encyclopedia of Genes and Genomes(GO-KEGG),and the docking mode of active components with core targets was simulated with AutoDock.Thirty rats were randomly divided into five groups:control(0.9%NaCl),model(0.9%NaCl),positive drug(1g/kg Guilong cough and asthma relief),low-dose(2 g/kg),and high-dose(8 g/kg)Lysionotus pauciflorus Maxim.groups.After CB modeling,lung tissues were collected for HE staining to judge the success of the modeling;gastric administration was then performed once a day for 28 days.Western blot and RT-PCR were used to detect the expression of proteins and mRNAs such as protein kinase B(AKT1),peroxisome proliferator-activated receptor γ(PPARγ),and nuclear factor-κB(NF-κB p65)in lung tissues;ELISA was used to detect serum levels of tumor necrosis factor α(TNF-α),interleukin 1β(IL-1β),and interferon γ(INF-γ).Results Lysionotus pauciflorus Maxim.had 18 active components with 92 intersecting targets,including core targets like AKT1 and PPARγ.GO-KEGG enrichment mainly involved immune and inflammation-related phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt),mitogen-activated protein kinase(MAPK)signaling pathways.Compared with blank group,PPARγ protein and mRNA expression in lung tissue of model group decreased,while NF-κB p65 and AKT1 protein and mRNA expression increased(P<0.05).Compared with model group,PPARγ protein and mRNA expression in lung tissue of rats in positive drug group,low-Lysionotus pauciflorus group and high-Lysionotus pauciflorus group were increased to some extent,while NF-κB p65 and AKT1 protein and mRNA expression were decreased to some extent.The difference of lung tissue expression was most significant in high-Lysionotus pauciflorus group(P<0.05).The active components of Lysionotus pauciflorus Maxim.stably bind to AKT1 and PPARγ.Animal experiments showed that the levels of TNF-α,IL-1 β,and INF-γ in the serum of rats in the model group and low-dose Lysionotus pauciflorus Maxim.group were higher than those in the control group(P<0.05),and those in the positive drug group and high-dose Lysionotus pauciflorus Maxim.group were lower than those in the model group(P<0.05).Conclusion Lysionotus pauciflorus Maxim.exerts therapeutic effects on CB by acting on AKT1,PPARγ,and NF-κB p65.

Lysionotus pauciflorus Maxim.chronic bronchitisbioinformatics analysisin vivo experimentslung tissuePI3K-AKT signaling pathway

胡子怡、冯静、杨向前、王茜、赵新越、吴宁、钟曦、吴昌学

展开 >

贵州医科大学基础医学院化学与生物化学实验室,贵州贵阳 550025

贵州医科大学医学分子生物学重点实验室,贵州贵阳 550004

杆努尽烟 慢性支气管炎 生信分析 体内实验 肺组织 PI3K-AKT信号通路

国家自然科学基金贵州省科技计划项目贵州省大学生创新创业计划项目贵州省大学生创新创业计划项目贵州省大学生创新创业计划项目

8206776黔科合LH字[2020]1Y388202010660005S202210660094S202310660047

2024

贵州医科大学学报
贵阳医学院

贵州医科大学学报

CSTPCD
影响因子:0.827
ISSN:2096-8388
年,卷(期):2024.49(4)
  • 26